301 related articles for article (PubMed ID: 6152481)
1. Neurochemical anatomy of movement disorders.
Young AB; Penney JB
Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides in the basal ganglia.
Graybiel AM
Res Publ Assoc Res Nerv Ment Dis; 1986; 64():135-61. PubMed ID: 2425403
[No Abstract] [Full Text] [Related]
3. Functional anatomy of thalamus and basal ganglia.
Herrero MT; Barcia C; Navarro JM
Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
[TBL] [Abstract][Full Text] [Related]
4. Chapter 33: the history of movement disorders.
Lanska DJ
Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
[TBL] [Abstract][Full Text] [Related]
5. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
[TBL] [Abstract][Full Text] [Related]
6. [Somatotopy in the basal ganglia].
Nanbu A
Brain Nerve; 2009 Dec; 61(12):1383-94. PubMed ID: 20034305
[TBL] [Abstract][Full Text] [Related]
7. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
8. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
9. [Neuraminergic conception of extrapyramidal syndromology].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
[No Abstract] [Full Text] [Related]
10. [Physiology and pharmacology of extrapyramidal tract].
Yoshida M; Mizuno Y
Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
[No Abstract] [Full Text] [Related]
11. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.
Kopell BH; Rezai AR; Chang JW; Vitek JL
Mov Disord; 2006 Jun; 21 Suppl 14():S238-46. PubMed ID: 16810674
[TBL] [Abstract][Full Text] [Related]
12. [Movement disorders and basal ganglia function].
Dietrichs E
Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
[TBL] [Abstract][Full Text] [Related]
13. Network biomarkers for the diagnosis and treatment of movement disorders.
Poston KL; Eidelberg D
Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitters and neurodegenerative disorders.
Kanazawa I
Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
[TBL] [Abstract][Full Text] [Related]
15. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].
Arushanian EB
Usp Fiziol Nauk; 1979; 10(2):45-72. PubMed ID: 38580
[No Abstract] [Full Text] [Related]
16. Three types of akinesia in the progressive course of Parkinson's disease.
Narabayashi H
Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577
[No Abstract] [Full Text] [Related]
17. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
18. The basal ganglia-circa 1982. A review and commentary.
Mehler WR
Appl Neurophysiol; 1981; 44(5-6):261-90. PubMed ID: 6126156
[TBL] [Abstract][Full Text] [Related]
19. Neurochemistry of dementia.
Whitehouse PJ; Unnerstall JR
Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
[TBL] [Abstract][Full Text] [Related]
20. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
